Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China flag China · Delayed Price · Currency is CNY
15.74
+0.14 (0.90%)
Feb 3, 2026, 3:04 PM CST

SHE:002082 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
1,3701,4271,5311,7701,92313,678
Other Revenue
16.1116.1110.5116.467.8623.67
1,3871,4431,5421,7861,93113,702
Revenue Growth (YoY)
-13.26%-6.39%-13.69%-7.47%-85.91%-17.91%
Cost of Revenue
897.71847.18918.18852.57999.2712,364
Gross Profit
488.87596.19623.76933.85931.331,338
Selling, General & Admin
365.01443.02458.13579.71571.77672.45
Research & Development
66.8859.8753.9859.176.2184.89
Other Operating Expenses
45.2919.4217.8923.4820.4322.7
Operating Expenses
474.65521.42553.57701.27720.65899.44
Operating Income
14.2174.7770.19232.58210.69438.07
Interest Expense
-37.39-38.5-46.48-33.2-35.6-56.68
Interest & Investment Income
18.7418.975.1910.75235.7618.47
Currency Exchange Gain (Loss)
-0.05-0.05-4.53-0.82-0.931.81
Other Non Operating Income (Expenses)
2.62-1.84-1.41-0.74-1.27-8.69
EBT Excluding Unusual Items
-1.8753.3522.96208.58408.65392.98
Impairment of Goodwill
----67.78-19.27-74.4
Gain (Loss) on Sale of Investments
3.882.94-1.83-0.56-2.39-
Gain (Loss) on Sale of Assets
-10.8815.740.12-0.95-1.21-0.31
Asset Writedown
-23.14-21.75-2.88-22.5-28.09-1.97
Other Unusual Items
56.058.6811.56-16.663.4631.45
Pretax Income
24.0458.9529.93100.13361.14347.76
Income Tax Expense
13.7613.713.626.43199.9855.54
Earnings From Continuing Operations
10.2945.2526.3373.71161.16292.21
Minority Interest in Earnings
3.9210.1922.8819.555.35-7.28
Net Income
14.255.4449.2193.26166.51284.94
Net Income to Common
14.255.4449.2193.26166.51284.94
Net Income Growth
-86.06%12.67%-47.23%-43.99%-41.56%-3.26%
Shares Outstanding (Basic)
488616615622617606
Shares Outstanding (Diluted)
488616615622617606
Shares Change (YoY)
-21.16%0.15%-1.06%0.82%1.73%21.45%
EPS (Basic)
0.030.090.080.150.270.47
EPS (Diluted)
0.030.090.080.150.270.47
EPS Growth
-82.32%12.50%-46.67%-44.44%-42.55%-20.34%
Free Cash Flow
-258.2623.11-201.59-406.88-263.42-408.24
Free Cash Flow Per Share
-0.530.04-0.33-0.65-0.43-0.67
Dividend Per Share
--0.0800.120-0.200
Dividend Growth
---33.33%--33.33%
Gross Margin
35.26%41.30%40.45%52.28%48.24%9.76%
Operating Margin
1.03%5.18%4.55%13.02%10.91%3.20%
Profit Margin
1.02%3.84%3.19%5.22%8.63%2.08%
Free Cash Flow Margin
-18.63%1.60%-13.07%-22.78%-13.64%-2.98%
EBITDA
111.26170.42163.98337.3305.12545.18
EBITDA Margin
8.02%11.81%10.63%18.88%15.80%3.98%
D&A For EBITDA
97.0495.6593.79104.7294.43107.11
EBIT
14.2174.7770.19232.58210.69438.07
EBIT Margin
1.03%5.18%4.55%13.02%10.91%3.20%
Effective Tax Rate
57.22%23.25%12.04%26.39%55.37%15.97%
Revenue as Reported
1,3871,4431,5421,7861,93113,702
Advertising Expenses
-1.493.731.324.863.81
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.